PTEN and neoplasm: Other signatures of prognostic value, even after adjusting for other clinicopathological factors, encompassed prognostically favorable and unfavorable signatures related to cytotoxic cells and signatures related to genetic tumor mutational responses (p53, BRCAness, and HRD), as well as PTEN, respectively.